Gyre Therapeutics, Inc.
NASDAQ:GYREBiotechnology
Healthcare
$4.34 -0.15%
+$0.00 today
- Market cap
- $475.02M
- Beta
- 4.92
- P/E (TTM)
- -88.3
- EPS (TTM)
- -$0.07
52W Low $5.44High $9.42
Volume 0.47M
Average 0.09M
Price history
Gyre Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-42.67%
Period high
$8.76
Period low
$4.01
Latest
$4.34
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 6, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Oct 22, 2026 | Oct 22, 2026 | |
| 8-K | Sep 1, 2026 | Sep 1, 2026 | |
| S-8 | Aug 27, 2026 | Aug 28, 2026 | |
| 8-K | Aug 26, 2026 | Aug 26, 2026 | |
| 10-Q | Aug 7, 2026 | Aug 7, 2026 | |
| 8-K | Aug 7, 2026 | Aug 7, 2026 | |
| 3 | Aug 4, 2026 | Aug 4, 2026 | |
| 4 | Aug 4, 2026 | Aug 4, 2026 | |
| 4 | Aug 4, 2026 | Aug 4, 2026 | |
| 3 | Aug 4, 2026 | Aug 4, 2026 | |
| EFFECT | Aug 3, 2026 | Aug 4, 2026 | |
| 8-K | Jul 16, 2026 | Jul 16, 2026 | |
| 8-K/A | Jul 15, 2026 | Jul 15, 2026 |
Competitors
Who does Gyre Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about GYRE's filings, answered from its disclosures.
What is the latest GYRE filing?
The latest filing shown is 10-Q dated Nov 6, 2026.
How many recent filings does GYRE have?
Intrinsic Alpha currently shows 20 recent filings for GYRE.
Continue the stock analysis
Jump to another research area for this company.